News

Perceived Dyspnea Affects COPD Quality of Life Outcomes


 

AT THE ANNUAL MEETING OF THE AMERICAN COLLEGE OF CHEST PHYSICIANS

Dr. Adams disclosed that she has received grant money for research from the Chest Foundation, the NIH, the Veterans Affairs Cooperative Studies Program, Bayer, Boehringer Ingelheim, Centocor, GlaxoSmithKline, Novartis, Pfizer, and Schering-Plough. She also has received honoraria for speaking from ABCam, Altana, AstraZeneca, Aventis, Bayer, Boehringer Ingelheim, GSK, Novartis, AG, Mycomed, Pfizer, and Schering-Plough.

Pages

Recommended Reading

Stopping LABA Therapy May Worsen Controlled Asthma
MDedge Internal Medicine
Therapy-Resistant Asthma May Be Neither
MDedge Internal Medicine
Budesonide Reduces Adult Height in Kids With Asthma
MDedge Internal Medicine
Tiotropium Cut Exacerbations in Poorly Controlled Asthma
MDedge Internal Medicine
FDA Reviewing Possible Heart Failure Risk with Pramipexole
MDedge Internal Medicine
Linezolid May Predict MRSA Pneumonia Treatment Success
MDedge Internal Medicine
Epic Progress Seen in Reducing Pneumococcal Infections
MDedge Internal Medicine
CDC Issues First Report for 2012-2013 Flu Season
MDedge Internal Medicine
FDA Approves Abraxane for Non-Small Cell Lung Cancer
MDedge Internal Medicine
Shades of SARS? New Virus Took Root in Pneumonia Patient
MDedge Internal Medicine